Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Careers
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
MCP for Agents
Advertise with Us
Top Online Brokers
Gold IRA Companies
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Gold IRA Review
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NTLA
Stock Latest News
Ratings
Intellia Therapeutics: Buy Rating Reiterated on De-Risked HAE and ATTR Pipelines; $29 DCF-Based Price Target Maintained
7d ago
NTLA
Premium
The Fly
Intellia Therapeutics price target raised to $17 from $13 at Bernstein
21d ago
NTLA
Premium
The Fly
Intellia Therapeutics price target lowered to $25 from $30 at H.C. Wainwright
21d ago
NTLA
Premium
The Fly
FDA Commissioner Marty Makary resigns
22d ago
AZN
BMY
Premium
The Fly
Intellia Therapeutics price target lowered to $19 from $20 at BofA
22d ago
NTLA
Premium
The Fly
Intellia Therapeutics price target lowered to $49 from $58 at Canaccord
22d ago
NTLA
Premium
The Fly
Intellia Therapeutics reports Q1 EPS (81c), consensus (90c)
23d ago
NTLA
Premium
Ratings
Myles Minter Reiterates Buy on Intellia (NTLA), Citing Extended Cash Runway and Strong Phase III Data for Lonvoguran Ziclumeran
23d ago
NTLA
Premium
The Fly
Cathie Wood’s ARK Investment buys 141K shares of Intellia Therapeutics today
1M ago
NTLA
Premium
Company Announcements
Intellia Therapeutics Prices Public Equity Offering to Fund Pipeline
1M ago
8K
NTLA
Premium
The Fly
Cathie Wood’s ARK Investment buys 2.4M shares of Intellia Therapeutics today
1M ago
NTLA
Premium
The Fly
Unusually active option classes on open April 29th
1M ago
CVS
Premium
The Fly
Intellia Therapeutics 16.7M share Secondary priced at $10.75
1M ago
NTLA
Premium
Market News
Cathie Wood Makes $14M Bet on Alphabet Stock Ahead of Today’s Q1 Earnings, Buys the Dip in CRWV and Trims Bullish Stake
1M ago
BLSH
CRWV
Premium
The Fly
Cathie Wood’s ARK Investment buys 596K shares of Intellia Therapeutics today
1M ago
NTLA
Premium
Market News
Cathie Wood Offloads Rocket Lab Stock (RKLB) Despite 3% Jump, Buys the Dip in Intellia (NTLA)
1M ago
ARKG
ARKK
Premium
The Fly
Intellia Therapeutics price target raised to $13 from $7 at Baird
1M ago
NTLA
Premium
The Fly
Intellia Therapeutics price target raised to $58 from $48 at Canaccord
1M ago
NTLA
Premium
The Fly
Intellia Therapeutics price target raised to $9 from $8 at Goldman Sachs
1M ago
NTLA
Premium
The Fly
Intellia Therapeutics price target raised to $30 from $28 at Citizens
1M ago
NTLA
Premium
The Fly
Cathie Wood’s ARK Investment buys 264K shares of Intellia Therapeutics today
1M ago
NTLA
Premium
The Fly
Intellia Therapeutics announces $150M common stock offering
1M ago
NTLA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
